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Abstract 
This study examined weight control motivation among obese and overweight men who sought weight loss treatment with training 
schedule. Several measurement assessed the frequency of cognitive and physical performance related to weight control and 
resentment and doubt in continue the weight lose program. Omega-3 Polyunsaturated fatty acids supplementation was 
associated with a progress of physiological activities in gym, particularly those involving multifarious control programs. These 
findings are discussed in terms of the influence of Omega-3 on the central nervous system to control depression. There were 
significant differences (p < 0.05) in the Omega-3 supplementation intake compared with placebo treatment as a control.  
© 2014 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of the Academic World Education and Research Center. 
Keywords: Omega-3, cognitive, weight lose, depression 
1. Introduction 
    Polyunsaturated fatty acids include the family of Omega-6 (n-6 fatty acids) and Omega-3(n-3 fatty acids) fatty 
acids. Some Omega-6 fatty acids, such as arachidonic acid, can be manufactured in the body using linoleic acid as a 
starting point and other Omega-3 fatty acids, such as eicosapentaenoc acid and docosahexaenoic acid are 
manufactured in the body using alpha linoleic acid as a starting point (Figueroa et al., 2013; Oddy et al., 2011).  On 
the basis of the influence of Omega-3 on neuronal activity, this study investigated the possible effect of Omega-3 on 
cognitive functions in weight lose subjects receiving Omega-3 fatty acid supplementation and performing a 
progression of physical and cognitive tests. In addition, given the purported benefits of omega-3. 
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Polyunsaturated fatty acids  on the depressive disorder and physical treatment in weight lose, it has been 
hypothesized that supplementation with these fatty acids may enhance the beneficial effects of physical activity, 
potentiating enhanced lipid oxidation and improvements in exercise performance (Mickleborough, 2013; Karr et al., 
2011). In weight lose procedure; depression is a serious affective illness with a high prevalence rate. The occurrence 
of depression is commonly comorbid with obesity. Given the purported benefits of n-3 on the fat metabolism, it has 
been speculated that supplementation may augment the beneficial effects of physical activity, potentiating superior 
reductions in body fat and improvements in exercise performance (De Caterina, 2011). One of the indications of 
inflammation is muscle soreness that can occur in both privileged class in sports and normal human adults. Muscle 
soreness, sometimes called delayed onset muscle soreness, is distinguished as a sort of soreness that is usually 
caused by new or heavy physical activities. The exercises that most frequently cause DOMS are primarily exercises 
of eccentric muscle action i.e.: where a muscle generates tension to control the rate at which it lengthens (MacIntyre 
et al., 1995; Wessel and Wan, 1994). The delayed onset muscle soreness generally occurs within 24-48 hours 
following exercise, may be associated with swelling, tenderness and discomfort, and may be experienced up to 1 
week following heavy exercise (Clarkson and Hubal, 2002; Cleary et al., 2002; Wessel and Wan, 1994). models that 
have been tested for their potential to alleviate delayed onset muscle soreness include massage therapy, stretching, 
pharmacologic anti-inflammatory drugs and dietary supplements including omega-3 dietary supplements (Hyldahl et 
al., 2010; Herbert et al., 2011). The hypotheses that omega-3 dietary supplementation may reduce delayed onset 
muscle soreness posits that higher systemic omega-3 levels correlate to increased omega-3 concentration in the 
muscle cell wall thus enhance stretch and flexibility and reducing the risk of muscle cell injury during heavy 
physical activity in weight lose program. A number of studies have focused on supplementation with long chain 
Omega-3 polyunsaturated fatty acids enhance weight loss, especially on how can affect under regular exercise and 
heavy exercise in short term for reduction weight. In the present study these experimental procedures were used to 
evaluate the possible effects of Omega-3 on neuro-psychological functions in cognitive and physical elements. 
2. Methodology 
     All participants and normal controls were fully informed of the purpose of this study, the nature of the 
association with health benefits, and were required to read and sign an informed consent form. The experiment was 
carried out on healthy voluntary subjects have no personal history of sever disease which comprised 75 males over 
the age of 18 were allowed to participate in the study (age: 29.1+ 4.72, BMI: 26.5 + 3.7) if they were otherwise 
healthy, did not currently take any dietary supplements containing fish oil or omega-3 and were able to read and sign 
the informed consent. The subjects were all evaluated and received a daily supplementation of Omega- 3 for 65 
days. Similarly, a control group of 25 subjects was evaluated with the same experimental procedure and received a 
daily a supplementation of olive oil, considered as placebo (P), for 35 days. Subjects had a BMI >25 kg/m2 were 
recruited from members of the local gym in north area of Tehran city. All applicants completed a classified 
schedule, to ensure that they could safely adhere to the physical activity program with psychological aspects. 
 
2.1 Measures 
 
x Body Mass Index: Anthropometric Measures included weight and height measured using a digital scale and 
stadiometer. Weight was measured on all participants at baseline and at yearly assessment visits, using a 
digital scale (model EB-9008; CAMRY). Height was measured at baseline using a standard stadiometer. 
x Behavioural adherence: Three measures were used to estimate adherence to the provided treatment 
schedule. First, attendance of all on-site individual treatment sessions was recorded during short-term 
treatment. 
x Questionnaire development: A widespread self-administered questionnaire was developed, consisting of 
dietary habits, lifestyles, obesity stress, obsession to lose weight, physical activities progress, and weight 
loss behaviours(developed and modified according to the Beck Depression Inventory–II ,1996) (Beck et 
al., 1961). This evaluation composed 50 four-answer questions.  
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Table 1: depression levels obtained of treatment group. 
Depression 
Level 
Week 1 
 
Week2 
 
Week 3 
 
Week 4 
 
Week 5 
 
Week 6 
 
Week 7 
 
Week 8 
 
p-value 
Normal 57.5 % 58.8 % 61.5  % 63.4 % 65.8 % 67.3 % 77.2 % 78.3 % 0.002* 
Mild 20.4 % 22.6 % 26.8 % 24.6 5 25.3 % 21.4 % 16.8 % 17.9 % 0.0219* 
Relatively 9.8 % 7.2 % 6.3 % 7.7 % 6.2 % 5.9 % 3.3 % 1.7 % 0.006* 
Moderate 6.7 % 6.2 % 3.4 % 4.3 % 1.7 % 3.3 % 2.1 % 1.3 % 1.570 * 
Severe 6.5 % 5.2 % 2 % 0.9 % 1 % 2.1 % 0.8 % 0.8 % 0.005* 
Excessive 0 0 0 0 0 0 0 0  
*Significantly different at P < 0.05 
 
2.2.Statistical analysis 
Group differences were determined using a one way analysis of variance for repeated measures, for continuous 
variables. Partial correlation and mixed model regression coefficients were used to evaluate the association between 
the variables studied. The statistical software program SPSS (SPSS Co, Chicago IL, version 17). All statistical tests 
were performed and considered significant at a P ≤ 0.05. 
3. Result 
The main finding of the study is that in adult obese male, the impending protective effect of the n-3 omega fatty 
acids in relation to positive effects in physical activity progress under muscle soreness associated with cognitive 
improvement. The results of this study by gender showed that 78.3 % of depression levels obtained in week 8 of 
adult men presented in this program, 17.9 %% with mild symptoms, and 1.7 % were relatively (Table 1). The 
present study showed that there is a difference in the rate of depression among adult men in short-term of reducing 
weight program, which is similar to the well known idea that depression is more experienced by men in beginning of 
treatment which vastly related to pain and muscle damage (Howatson and Van Someren, 2008) . Moreover, 
depressive disorders are significantly more experienced. Some epidemiological, community and clinical studies 
were indicated that obese commonly were found to present higher levels in reducing weight treatment (Palinkas et 
al., 1996; Dixon et al., 2003). Dietary supplementation of omega-3 has become more common and is being 
prospectively experienced for its effect on a various of physiological conditions and behavioural disorders, 
metabolic conditions and physical performance (Mickleborough, 2013). This study and other available 
evidence indicate that oxidative stress and inflammatory responses in physical activities in individual treatment have 
been observed in participants who engage in physical exercise (Peet et al., 1998; An et al., 2009). Recently finding 
indicate that the efficacy of  EICOSAPENTAENOC ACID  (2,224 mg/day) and DOCOSAHEXAENOIC ACID 
(2,208 mg/day) for 6 weeks on resting and exercise-induced inflammation, oxidative stress, and aerobic exercise 
(Bloomer et al., 2009). While, at present, the limited human data do not recommend that omega-3 PUFA 
supplementation is effective in enhancing exercise performance, it has been demonstrated that omega-3 
Polyunsaturated fatty acids can affect not only cognitive function but also depression level and may act as a mood 
stabilizer (Parker et al., 2006; Fontani et al., 2005). Given the positive effect of physical activity enhance 
neurological system on happiness expression, supplementation may help alleviate depression in treatment, which 
could indirectly benefit exercise performance and improve cognitive to continue the treatment (Fox, 1999). 
Nevertheless, commercial supplements are a common remedy for weight-lose which have side effect for the short-
term treatment, medications have unwanted side-effects with safety effects.  
4. Conclusion  
 The addition of Omega-3 to a very low calorie diet (schedule dietary) results in a greater Body Mass Index loss 
and hip circumference reduction in severely obese men during an inpatient short-term weight-reducing regimen with 
cognitive development in adherence to weight-reducing program to reduce depression in difficulty of physical 
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exercise. Most significantly, the impending protective effect of the n-3 omega fatty acids in relation to positive 
effects in physical activity progress under muscle soreness associated with cognitive improvement. More research is 
needed in order to elucidate how omega-3 fatty acid supplementation may affect obese person in reducing weight 
treatment and other physical manifestations following heavy exercise in adults which could associate with lifestyle 
and dietary intake in treatment. 
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